|
Apr 17
|
NexgenRx Announces Declaration of Divdend
|
|
Apr 3
|
NexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA
|
|
Oct 7
|
NexgenRX Announces Director Re-Appointment
|
|
Aug 15
|
NexgenRx Announces Second Quarter Results, With Over 19% Revenue Growth and Positive EBITDA
|
|
Jun 14
|
NexgenRx Announces Declaration of Dividend
|
|
May 17
|
NexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record Earnings
|
|
May 16
|
NexgenRx Announces Annual Meeting Results
|
|
Dec 29
|
NexgenRx Announces Director Resignation
|
|
Dec 20
|
NexgenRX Announces Declaration of Dividend
|